Does DINUTUXIMAB BETA Cause Capillary leak syndrome? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Capillary leak syndrome have been filed in association with DINUTUXIMAB BETA. This represents 3.8% of all adverse event reports for DINUTUXIMAB BETA.
6
Reports of Capillary leak syndrome with DINUTUXIMAB BETA
3.8%
of all DINUTUXIMAB BETA reports
1
Deaths
0
Hospitalizations
How Dangerous Is Capillary leak syndrome From DINUTUXIMAB BETA?
Of the 6 reports, 1 (16.7%) resulted in death.
Is Capillary leak syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DINUTUXIMAB BETA. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DINUTUXIMAB BETA Cause?
Off label use (82)
Pyrexia (57)
Pain (46)
Death (20)
Neoplasm progression (20)
Device related bacteraemia (17)
Device related infection (16)
Diarrhoea (11)
Therapy partial responder (11)
Cough (10)
What Other Drugs Cause Capillary leak syndrome?
GEMCITABINE (134)
TAGRAXOFUSP-ERZS (110)
PACLITAXEL (97)
CYCLOPHOSPHAMIDE (86)
DOCETAXEL (81)
CYTARABINE (68)
METHOTREXATE (65)
NIVOLUMAB (61)
RITUXIMAB (58)
FILGRASTIM (52)
Which DINUTUXIMAB BETA Alternatives Have Lower Capillary leak syndrome Risk?
DINUTUXIMAB BETA vs DIOSMIN
DINUTUXIMAB BETA vs DIOSMIN\HESPERIDIN
DINUTUXIMAB BETA vs DIOVAN
DINUTUXIMAB BETA vs DIPHENHYDRAMINE
DINUTUXIMAB BETA vs DIPHENHYDRAMINE\IBUPROFEN